From the Departments of Pathology and Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland (VandenBussche).
the Biostatistics Division, College of American Pathologists, Northfield, Illinois (Nwosu, Souers).
Arch Pathol Lab Med. 2024 May 1;148(5):531-537. doi: 10.5858/arpa.2023-0010-CP.
In recent years, several reporting systems have been developed by national and international cytopathology organizations to standardize the evaluation of specific cytopathology specimen types.
To assess the current implementation rates, implementation methods, and barriers to implementation of commonly used nongynecologic reporting systems in cytopathology laboratories.
Data were analyzed from a survey developed by the College of American Pathologists Cytopathology Committee and distributed to participants in the College of American Pathologists Nongynecologic Cytopathology Education Program mailing.
Nongynecologic reporting systems with the highest rate of adoption were the Bethesda System for Reporting Thyroid Cytopathology, 2nd edition (74.1%; 552 of 745); the Paris System for Reporting Urinary Cytology (53.9%; 397 of 736); and the Milan System for Reporting Salivary Gland Cytopathology (29.1%; 200 of 688). The most common reason given for not adopting a reporting system was satisfaction with a laboratory's current system. Implementation varied among laboratories with regard to which stakeholders were involved in deciding to implement a system and the amount of education provided during the implementation process.
The implementation of nongynecologic reporting systems in cytopathology laboratories was highly variable.
近年来,一些国家和国际细胞学组织已经开发出了几种报告系统,以规范对特定细胞学标本类型的评估。
评估目前在细胞学实验室中常用的非妇科报告系统的实施率、实施方法和实施障碍。
数据分析来自美国病理学家学院细胞学委员会开发的一项调查,并分发给美国病理学家学院非妇科细胞学教育计划的参与者。
采用率最高的非妇科报告系统是第 2 版甲状腺细胞病理学报告贝塞斯达系统(74.1%;745 例中的 552 例)、巴黎尿细胞学报告系统(53.9%;736 例中的 397 例)和米兰唾液腺细胞病理学报告系统(29.1%;688 例中的 200 例)。不采用报告系统的最常见原因是对实验室现有系统的满意。在决定实施系统时涉及的利益相关者以及在实施过程中提供的教育量方面,实验室之间的实施情况存在差异。
在细胞学实验室中,非妇科报告系统的实施情况差异很大。